Conference Coverage: ASH 2025 – Focus on Leukemia
Latest expert perspectives on emerging research trends, therapeutic advancements, and their influence on clinical decision-making in leukemia
December 15, 2025
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Members
Valeria Santini, MD
University of Florence, Italy
Josep-María Ribera, MD, PhD
Catalan Institute of Oncology, Barcelona, Spain
David Sallman, MD
Moffitt Cancer Center, Tampa, FL, USA
Naval Daver, MD
MD Anderson Cancer Center, Houston, TX, USA
Aaron Logan, MD, PhD
UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA
REPORT SNAPSHOT
- New Developments in Myelodysplastic Syndromes (MDS)
- Advances in Acute Myeloid Leukemia (AML): Newly Diagnosed
- Advances in AML: Relapsed/Refractory
- Advances in Acute Lymphoblastic Leukemia (ALL): Newly Diagnosed
- Advances in ALL: Relapsed/Refractory
